Quality of Life and Functional Outcomes with Tapentadol Prolonged Release in Chronic Musculoskeletal Pain: Post Hoc Analysis

Cesar Margarit Ferri1 Hospital General Universitario de Alicante, Alicante, 03010, SpainView further author information

Silvia Natoli2 University of Rome Tor Vergata, Department of Clinical Science & Translational Medicine & Unit of Pain Therapy, Polyclinic of Tor Vergata, Rome, 00133, ItalyView further author information

Paz Sanz-Ayan3 Hospital Universitario 12 de Octubre; Department of Rehabilitation, Hospital Universitario 12 de Octubre, Madrid, 28041, SpainView further author information

Alberto Magni4 Italian College of General Practitioners & Primary Care, Florence, 50141, ItalyView further author information

Carlos Guerrero5 Hospital Universitario Fundación Santa Fe, Bogotá110121, Universidad de los Andes, ColombiaView further author information

Argelia Lara-Solares6 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, MexicoView further author information

Hiltrud Liedgens7 Global Market Access, Grünenthal GmbH, Aachen, 52099, GermanyCorrespondence[email protected]
View further author information

Guido Thömmes8 R&D – Development – Data Sciences, Grünenthal GmbH, Aachen, 52099, GermanyView further author information

Ravi Karra9 Global Medical Affairs, Grünenthal GmbH, Aachen, 52099, GermanyView further author information

show all

Quality of Life and Functional Outcomes with Tapentadol Prolonged Release in Chronic Musculoskeletal Pain: Post Hoc Analysis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Quality of Life and Functional Outcomes with Tapentadol Prolonged Release in Chronic Musculoskeletal Pain: Post Hoc Analysis

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date